Zobrazeno 1 - 10
of 18 266
pro vyhledávání: '"Adverse Drug Reactions"'
Publikováno v:
Zhongguo quanke yixue, Vol 28, Iss 02, Pp 250-256 (2025)
Background Currently, the treatment of refractory epilepsy (RE) in children is still a difficult point in epilepsy treatment. In China, pirenzapine (PER) is still a new drug for treating RE in children, and there is currently a lack of recommendation
Externí odkaz:
https://doaj.org/article/d30498c9228b45eb9c25f257523084fe
Autor:
Alsulami FT
Publikováno v:
Patient Preference and Adherence, Vol Volume 18, Pp 2495-2506 (2024)
Fahad T Alsulami Clinical Pharmacy Department, College of Pharmacy, Taif University, Taif, 21944, Saudi ArabiaCorrespondence: Fahad T Alsulami, Clinical Pharmacy Department, College of Pharmacy, Taif University, Taif, 21944, Saudi Arabia, Email F.als
Externí odkaz:
https://doaj.org/article/df72b43feae24ab29e3ba1bcd022f6a0
Publikováno v:
Clinical Pharmacology: Advances and Applications, Vol Volume 16, Pp 33-40 (2024)
Lina Naseralallah,1 Dima Nasrallah,2 Somaya Koraysh,1 Shimaa Aboelbaha,3 Tarteel Ali Hussain3 1Pharmacy Department, Hamad Medical Corporation, Doha, Qatar; 2College of Medicine, QU Health, Qatar University, Doha, Qatar; 3College of Pharmacy, QU Healt
Externí odkaz:
https://doaj.org/article/a2cd9d14a0854a538fed2c6fdfe9ff4a
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Indocyanine green (ICG) is a diagnostic dye commonly used in medical imaging and liver function monitoring. Given its widespread use, there is a need for detailed evaluations of its adverse drug reactions in real-world settings. As the compr
Externí odkaz:
https://doaj.org/article/2d9fae1ba3314effab9eaf989c6adce6
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 5, Pp 1646-1650 (2024)
Abstract Generalised pustular psoriasis (GPP) is characterised by a widespread rash with pustules and fever. Clinical and the histological overlap with the delayed hypersensitivity reaction acute generalised exanthematous pustulosis may delay the dia
Externí odkaz:
https://doaj.org/article/f36c1824f8494a90b7153442637ef833
Autor:
Johanna Seifert, Matthias A. Reinhard, Stefan Bleich, Andreas Erfurth, Waldemar Greil, Sermin Toto, Renate Grohmann, Catherine Glocker
Publikováno v:
Annals of General Psychiatry, Vol 23, Iss 1, Pp 1-22 (2024)
Abstract Background Clinical practice suggests that older adults (i.e., ≥ 65 years of age) experience adverse drug reactions (ADRs) more often than younger patients (i.e.,
Externí odkaz:
https://doaj.org/article/a8d7c9cc97584e3bb20a8454ca64466f
Autor:
Samuel Berihun Dagnew, Tilaye Arega Moges, Teklie Mengie Ayele, Samuel Agegnew Wondm, Taklo Simeneh Yazie, Fisseha Nigussie Dagnew
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Adverse drug reactions are more prevalent in geriatric patients and are frequently associated with a range of polypharmacy-related issues as well as some physiological aging-related alterations. These affect the pharmacokinetic an
Externí odkaz:
https://doaj.org/article/a2bdc4edfda74638b1e1f1b51968a7bd
Autor:
Narumol Trachu, Thanyanan Reungwetwattana, Jennis Meanwatthana, Chonlaphat Sukasem, Teerapat Majam, Wacharapol Saengsiwaritt, Jiraphun Jittikoon, Wanvisa Udomsinprasert
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract This study aimed to measure relative telomere length (RTL) in blood leukocytes of advanced-stage NSCLC patients either with or without Osimertinib-induced ADRs and determine whether RTL could serve as a biomarker of Osimertinib-induced ADRs.
Externí odkaz:
https://doaj.org/article/31980476529c47eebb660187cb7ab449
Publikováno v:
SRM Journal of Research in Dental Sciences, Vol 15, Iss 3, Pp 157-162 (2024)
Background India started the National Programme of Pharmacovigilance in 2005, which was renamed as Pharmacovigilance Programme of India in 2010. This is the main portal for detecting and reporting the adverse effects of drugs. Aim This study aimed to
Externí odkaz:
https://doaj.org/article/e036149218864fd086f14a5b1b5a3224
Publikováno v:
Risk Management and Healthcare Policy, Vol Volume 17, Pp 2557-2572 (2024)
Hind Alshehri,1 Adnan Alharbi,1 Noof Alqethami,2 Mohammed Alnuhait,1 Abdullah Alshammari,1 Abdulmalik S Alotaibi1 1Pharmaceutical Practices Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia; 2Clinical Pharmacy Department,
Externí odkaz:
https://doaj.org/article/4868317d1a3847ff9d0b9e701b4b920a